197 related articles for article (PubMed ID: 34538264)
21. TAGLN Is Downregulated by TRAF6-Mediated Proteasomal Degradation in Prostate Cancer Cells.
Wen F; Sun X; Sun C; Dong Z; Jia G; Bao W; Yu H; Yang C
Mol Cancer Res; 2021 Jul; 19(7):1113-1122. PubMed ID: 33771884
[TBL] [Abstract][Full Text] [Related]
22. RhoA/ROCK signaling mediates plasticity of scirrhous gastric carcinoma motility.
Matsuoka T; Yashiro M; Kato Y; Shinto O; Kashiwagi S; Hirakawa K
Clin Exp Metastasis; 2011 Oct; 28(7):627-36. PubMed ID: 21667311
[TBL] [Abstract][Full Text] [Related]
23. ECM compliance regulates osteogenesis by influencing MAPK signaling downstream of RhoA and ROCK.
Khatiwala CB; Kim PD; Peyton SR; Putnam AJ
J Bone Miner Res; 2009 May; 24(5):886-98. PubMed ID: 19113908
[TBL] [Abstract][Full Text] [Related]
24. Gastrin stimulates pancreatic cancer cell directional migration by activating the Gα12/13-RhoA-ROCK signaling pathway.
Mu G; Ding Q; Li H; Zhang L; Zhang L; He K; Wu L; Deng Y; Yang D; Wu L; Xu M; Zhou J; Yu H
Exp Mol Med; 2018 May; 50(5):1-14. PubMed ID: 29717112
[TBL] [Abstract][Full Text] [Related]
25. [Correlation of expression of RhoA (RhoC and their effector ROCK-1 with malignant phenotype of ovarian cancer cells in vitro].
Han ZQ; Zhang AL; Wu MF; Liu YL; Chen G; Li FJ; Gao QL; Liao GN; Lu YP; Wang SX; Ma D
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):385-8. PubMed ID: 15355639
[TBL] [Abstract][Full Text] [Related]
26. Active tissue stiffness modulation controls valve interstitial cell phenotype and osteogenic potential in 3D culture.
Duan B; Yin Z; Hockaday Kang L; Magin RL; Butcher JT
Acta Biomater; 2016 May; 36():42-54. PubMed ID: 26947381
[TBL] [Abstract][Full Text] [Related]
27. Cartilage Oligomeric Matrix Protein promotes epithelial-mesenchymal transition by interacting with Transgelin in Colorectal Cancer.
Zhong W; Hou H; Liu T; Su S; Xi X; Liao Y; Xie R; Jin G; Liu X; Zhu L; Zhang H; Song X; Yang C; Sun T; Cao H; Wang B
Theranostics; 2020; 10(19):8790-8806. PubMed ID: 32754278
[No Abstract] [Full Text] [Related]
28. Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels.
Wang C; Tong X; Yang F
Mol Pharm; 2014 Jul; 11(7):2115-25. PubMed ID: 24712441
[TBL] [Abstract][Full Text] [Related]
29. Activation of ERM-family proteins via RhoA-ROCK signaling increases intestinal P-gp expression and leads to attenuation of oral morphine analgesia.
Kobori T; Harada S; Nakamoto K; Tokuyama S
J Pharm Sci; 2013 Mar; 102(3):1095-105. PubMed ID: 23303573
[TBL] [Abstract][Full Text] [Related]
30. RhoA/ROCK-dependent moesin phosphorylation regulates AGE-induced endothelial cellular response.
Wang J; Liu H; Chen B; Li Q; Huang X; Wang L; Guo X; Huang Q
Cardiovasc Diabetol; 2012 Jan; 11():7. PubMed ID: 22251897
[TBL] [Abstract][Full Text] [Related]
31. TAGLN suppresses proliferation and invasion, and induces apoptosis of colorectal carcinoma cells.
Li Q; Shi R; Wang Y; Niu X
Tumour Biol; 2013 Feb; 34(1):505-13. PubMed ID: 23138394
[TBL] [Abstract][Full Text] [Related]
32. TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions.
Park GH; Lee SJ; Yim H; Han JH; Kim HJ; Sohn YB; Ko JM; Jeong SY
Oncol Rep; 2014 Oct; 32(4):1347-54. PubMed ID: 25109740
[TBL] [Abstract][Full Text] [Related]
33. LncNORAD interference inhibits tumor growth and lung cancer cell proliferation, invasion and migration by down-regulating CXCR4 to suppress RhoA/ROCK signaling pathway.
Wu Y; Shen QW; Niu YX; Chen XY; Liu HW; Shen XY
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5446-5455. PubMed ID: 32495879
[TBL] [Abstract][Full Text] [Related]
34. Targeting matrix stiffness-induced activation of retinal pigment epithelial cells through the RhoA/YAP pathway ameliorates proliferative vitreoretinopathy.
Zhang W; Han H
Exp Eye Res; 2021 Aug; 209():108677. PubMed ID: 34147507
[TBL] [Abstract][Full Text] [Related]
35. Deciphering Biophysical Modulation in Ovarian Cancer Cells.
Sarwar M; Sykes PH; Chitcholtan K; Evans JJ
Cell Biochem Biophys; 2021 Jun; 79(2):375-386. PubMed ID: 33433760
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.
Long X; Song K; Hu H; Tian Q; Wang W; Dong Q; Yin X; Di W
J Exp Clin Cancer Res; 2019 Aug; 38(1):345. PubMed ID: 31391118
[TBL] [Abstract][Full Text] [Related]
37. Serotonin/HTR1E signaling blocks chronic stress-promoted progression of ovarian cancer.
Qin X; Li J; Wang S; Lv J; Luan F; Liu Y; Chen Y; Chen X; Zhao Y; Zhu J; Piao Y; Zhang W; Shi Y; Xiang R; Qu P; Wang L
Theranostics; 2021; 11(14):6950-6965. PubMed ID: 34093864
[No Abstract] [Full Text] [Related]
38. Transgelin, a p53 and PTEN-Upregulated Gene, Inhibits the Cell Proliferation and Invasion of Human Bladder Carcinoma Cells in Vitro and in Vivo.
Tsui KH; Lin YH; Chang KS; Hou CP; Chen PJ; Feng TH; Juang HH
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31591355
[TBL] [Abstract][Full Text] [Related]
39. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.
Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L
Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724
[TBL] [Abstract][Full Text] [Related]
40. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.
Schmidt LJ; Duncan K; Yadav N; Regan KM; Verone AR; Lohse CM; Pop EA; Attwood K; Wilding G; Mohler JL; Sebo TJ; Tindall DJ; Heemers HV
Mol Endocrinol; 2012 May; 26(5):716-35. PubMed ID: 22456196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
